Influenza vaccine

Annual Two-Dose COVID-19 Vaccination Campaign Could Reduce Hospitalizations and Deaths, Study Suggests

Recent research suggests that an annual two-dose SARS-CoV-2 vaccination campaign could significantly reduce hospitalizations and deaths related to the virus. Administering a second dose of the vaccine five months after the initial dose could result in a substantial decrease in adverse outcomes, according to a study published in the Annals of Internal Medicine. The study emphasizes the potential benefits of adopting an annual vaccination campaign with the provision of a second dose for specific age groups, offering valuable insights for public health officials and policymakers as they continue to combat the ongoing threat of COVID-19.